Pfizer discussing Allergan offer at $370-$380 per share: source

(Reuters) - Pfizer Inc is in talks to acquire Allergan Plc for $370-$380 per share, according to a person familiar with the matter, valuing the potential deal at around $150 billion, the healthcare sector's biggest.